Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2008-4-8
pubmed:abstractText
We assessed the cost-effectiveness of adding a quadrivalent (6/11/16/18) human papillomavirus (HPV) vaccine to the current screening programme in the UK compared to screening alone.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-10023311, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-10451482, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-10819705, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-10905528, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-11305546, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-11934772, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-12564249, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-12807940, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-12838308, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-12915431, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-12918067, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-15051550, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-15147611, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-15266332, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-15863374, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-15894666, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-16060711, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-16168781, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-16684427, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-16740585, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-16949997, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-17117182, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-17146475, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-17276976, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-17370513, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-17494925, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-17494926, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-17499406, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-17585005, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-7559948, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-8110501, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-8386137, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-9540955, http://linkedlifedata.com/resource/pubmed/commentcorrection/18279515-9819106
pubmed:language
eng
pubmed:journal
pubmed:status
PubMed-not-MEDLINE
pubmed:issn
1478-7547
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4
pubmed:year
2008
pubmed:articleTitle
Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis.
pubmed:affiliation
Dept, of Obstetrics and Gynecology, Duke University, Durham, NC 27705, USA. kulas002@mc.duke.edu
pubmed:publicationType
Journal Article